Profil
Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.
Postes actifs de Gregory Madison
| Sociétés | Poste | Début |
|---|---|---|
| PROKIDNEY CORP. | Corporate Officer/Principal | 25/03/2026 |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Directeur/Membre du Conseil | - |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Provides research and experimental development on biotechnology | Directeur/Membre du Conseil | 18/06/2021 |
Anciens postes connus de Gregory Madison
| Sociétés | Poste | Fin |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Directeur Général | 24/07/2024 |
| KERYX BIOPHARMACEUTICALS | Directeur Général | 30/04/2018 |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Directeur/Membre du Conseil | 30/09/2014 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 07/02/2014 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2012 |
Formation de Gregory Madison
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Health Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Provides research and experimental development on biotechnology | Health Technology |
Shield Therapeutics Plc
Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops sedation and analgesia medicines | Health Technology |
ProKidney Corp.
ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
















